دورية أكاديمية

Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations.

التفاصيل البيبلوغرافية
العنوان: Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations.
المؤلفون: Vanbelleghem E; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium., Van Damme T; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium., Beyens A; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium., Symoens S; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium., Claes K; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium., De Backer J; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.; Department of Cardiology, Ghent University Hospital, Ghent, Belgium., Meerschaut I; Department of Pediatric Cardiology, University Hospital Brussels, Brussels, Belgium., Vanommeslaeghe F; Department of Nephrology, Ghent University Hospital, Ghent, Belgium., Delanghe SE; Department of Nephrology, Ghent University Hospital, Ghent, Belgium., van den Ende J; Department of Medical Genetics, Antwerp University Hospital and University of Antwerp, Antwerp, Belgium., Beyltjens T; Department of Medical Genetics, Antwerp University Hospital and University of Antwerp, Antwerp, Belgium., Scimone ER; Department of Pediatrics, Genetics Unit, MassGeneral for Children, Boston, MA, USA., Lindsay ME; Cardiovascular Genetics Program, Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Pediatric Cardiology Division, Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA., Schimmenti LA; Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA., Hinze AM; Division of Rheumatology, Mayo Clinic, Rochester, MN, USA., Dunn E; Department of Pediatrics, Division of Medical Genetic, Stanford University, Stanford, CA, USA., Gomez-Ospina N; Department of Pediatrics, Division of Medical Genetic, Stanford University, Stanford, CA, USA., Vandernoot I; ULB Center of Human Genetics, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Delguste T; ULB Center of Human Genetics, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Coppens S; ULB Center of Human Genetics, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Cormier-Daire V; Paris Cité University, Centre of Reference for Constitutional Bone Diseases (MOC), Department of Genetics, INSERM UMR 1163, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France., Tartaglia M; Molecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Garavelli L; Medical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Shieh J; Institute for Human Genetics and Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA., Demir Ş; Department of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey., Arslan Ateş E; Department of Medical Genetics, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey., Zenker M; Institute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany., Rohanizadegan M; Department of Medicine, Division of Translational Medicine & Human Genetics, University of Pennsylvania, Philadelphia, PA, USA., Rivera-Cruz G; Division of Reproductive Endocrinology and Infertility, Stanford University School of Medicine, Stanford, CA, USA., Douzgou S; Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway., Lin AE; Department of Pediatrics, Genetics Unit, MassGeneral for Children, Boston, MA, USA., Callewaert B; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. bert.callewaert@ugent.be.; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. bert.callewaert@ugent.be.
مؤلفون مشاركون: Myhre Syndrome Foundation
المصدر: European journal of human genetics : EJHG [Eur J Hum Genet] 2024 Sep; Vol. 32 (9), pp. 1086-1094. Date of Electronic Publication: 2024 Jul 12.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9302235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5438 (Electronic) Linking ISSN: 10184813 NLM ISO Abbreviation: Eur J Hum Genet Subsets: MEDLINE
أسماء مطبوعة: Publication: <2003->: London : Nature Publishing Group
Original Publication: Basel ; New York : Karger, [1992-
مواضيع طبية MeSH: Phenotype* , Smad4 Protein*/genetics , Intellectual Disability*/genetics , Intellectual Disability*/pathology , Intellectual Disability*/diagnosis, Humans ; Male ; Adult ; Female ; Cryptorchidism/genetics ; Cryptorchidism/pathology ; Adolescent ; Growth Disorders/genetics ; Growth Disorders/pathology ; Middle Aged ; Mutation, Missense ; Facies ; Genetic Association Studies ; Hand Deformities, Congenital
مستخلص: Myhre syndrome (MS, MIM 139210) is a rare multisystemic disorder caused by recurrent pathogenic missense variants in SMAD4. The clinical features have been mainly documented in childhood and comprise variable neurocognitive development, recognizable craniofacial features, a short stature with a pseudo-muscular build, hearing loss, thickened skin, joint limitations, diverse cardiovascular and airway manifestations, and increased fibrosis often following trauma or surgery. In contrast, adults with MS are underreported obscuring potential clinical variability. Here, we describe 24 adults with MS, including 17 diagnosed after the age of 18 years old, and we review the literature on adults with MS. Overall, our cohort shows a milder phenotype as well as lower mortality rates compared to what has been published in literature. Individuals with a codon 500 variant in SMAD4 present with a more pronounced neurodevelopmental and systemic phenotype. However, in contrast to the literature, we observe cardiovascular abnormalities in individuals with the p.(Arg496Cys) variant. In addition, we describe scoliosis as a new manifestation and we report fertility in two additional males with the p.(Arg496Cys). In conclusion, our study contributes novel insights into the clinical variability of MS and underscores the importance of variant-specific considerations, and we provide recommendations for the management of MS in adulthood.
(© 2024. The Author(s), under exclusive licence to European Society of Human Genetics.)
التعليقات: Erratum in: Eur J Hum Genet. 2024 Sep 10. doi: 10.1038/s41431-024-01690-z. (PMID: 39256535)
References: Solomon AM, Solomon BD. Age-related survey of clinical genetics literature and related resources. Am J Med Genet C Semin Med Genet. 2023;193:103–8. (PMID: 10.1002/ajmg.c.3204037046134)
Lin AE, Alali A, Starr LJ, Shah N, Beavis A, Pereira EM, et al. Gain-of-function pathogenic variants in SMAD4 are associated with neoplasia in Myhre syndrome. Am J Med Genet A. 2020;182:328–37. (PMID: 10.1002/ajmg.a.6143031837202)
Lindor NM, Kasperbauer JL, Hoffman AD, Parisi JE, Wang H, Warman M. Confirmation of existence of a new syndrome: LAPS syndrome. Am J Med Genet. 2002;109:93–9. (PMID: 10.1002/ajmg.1031611977156)
Oldenburg MS, Frisch CD, Lindor NM, Edell ES, Kasperbauer JL, O’Brien EK. Myhre-LAPs syndrome and intubation related airway stenosis: keys to diagnosis and critical therapeutic interventions. Am J Otolaryngol. 2015;36:636–41. (PMID: 10.1016/j.amjoto.2015.04.00525940662)
Lindor NM, Gunawardena SR, Thibodeau SN. Mutations of SMAD4 account for both LAPS and Myhre syndromes. Am J Med Genet A. 2012;158a:1520–1. (PMID: 10.1002/ajmg.a.3537422585601)
Lindor NM. LAPS syndrome and Myhre syndrome: two disorders or one? Am J Med Genet A. 2009;149a:798–9. (PMID: 10.1002/ajmg.a.3271919267408)
Myhre SA, Ruvalcaba RH, Graham CB. A new growth deficiency syndrome. Clin Genet. 1981;20:1–5. (PMID: 10.1111/j.1399-0004.1981.tb01798.x7296942)
Caputo V, Cianetti L, Niceta M, Carta C, Ciolfi A, Bocchinfuso G, et al. A restricted spectrum of mutations in the SMAD4 tumor-suppressor gene underlies Myhre syndrome. Am J Hum Genet. 2012;90:161–9. (PMID: 10.1016/j.ajhg.2011.12.011222439683257749)
Piccolo P, Mithbaokar P, Sabatino V, Tolmie J, Melis D, Schiaffino MC, et al. SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan. Eur J Hum Genet. 2014;22:988–94. (PMID: 10.1038/ejhg.2013.283243987903984901)
Kandhaya-Pillai R, Hou D, Zhang J, Yang X, Compoginis G, Mori T, et al. SMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome-the Myhre syndrome. Geroscience. 2021;43:1481–96. (PMID: 10.1007/s11357-020-00318-6334281098190230)
Priestley JRC, Rippert AL, Condit C, Izumi K, Kallish S, Drivas TG. Unmasking the challenges of Kabuki syndrome in adulthood: a case series. Am J Med Genet C Semin Med Genet. 2023;193:128–38. (PMID: 10.1002/ajmg.c.3205437296540)
Wallin L, Gillberg C, Fernell E, Gillberg C, Billstedt E. Neurodevelopmental and other psychiatric disorders in 22q11.2 deletion syndrome from childhood to adult age: prospective longitudinal study of 100 individuals. Am J Med Genet C Semin Med Genet. 2023;193:172–82. (PMID: 10.1002/ajmg.c.3205237248687)
Meerschaut I, Beyens A, Steyaert W, De Rycke R, Bonte K, De Backer T, et al. Myhre syndrome: a first familial recurrence and broadening of the phenotypic spectrum. Am J Med Genet A. 2019;179:2494–9. (PMID: 10.1002/ajmg.a.6137731595668)
Demir Ş, Alavanda C, Yeşil G, Aslanger AD, Ateş EA. A second family with Myhre syndrome caused by the same recurrent SMAD4 pathogenic variation (p.Arg496Cys). Mol Syndromol. 2023;14:175–80. (PMID: 10.1159/0005271493706434210090971)
Lin AE, Michot C, Cormier-Daire V, L’Ecuyer TJ, Matherne GP, Barnes BH, et al. Gain-of-function mutations in SMAD4 cause a distinctive repertoire of cardiovascular phenotypes in patients with Myhre syndrome. Am J Med Genet A. 2016;170:2617–31. (PMID: 10.1002/ajmg.a.3773927302097)
Yang DD, Rio M, Michot C, Boddaert N, Yacoub W, Garcelon N, et al. Natural history of Myhre syndrome. Orphanet J Rare Dis. 2022;17:304. (PMID: 10.1186/s13023-022-02447-x359078559338657)
Michot C, Le Goff C, Mahaut C, Afenjar A, Brooks AS, Campeau PM, et al. Myhre and LAPS syndromes: clinical and molecular review of 32 patients. Eur J Hum Genet. 2014;22:1272–7. (PMID: 10.1038/ejhg.2013.288244241214200423)
Cătană A, Simonescu-Colan R, Cuzmici-Barabaș Z, Militaru D, Iordănescu I, Militaru MS. First documented case of Myhre syndrome in Romania: a case report. Exp Ther Med. 2022;23:323. (PMID: 10.3892/etm.2022.11252353866168972842)
Cappuccio G, Brunetti-Pierri N, Clift P, Learn C, Dykes JC, Mercer CL, et al. Expanded cardiovascular phenotype of Myhre syndrome includes tetralogy of Fallot suggesting a role for SMAD4 in human neural crest defects. Am J Med Genet A. 2022;188:1384–95. (PMID: 10.1002/ajmg.a.6264535025139)
Inoue K, Eiro T, Semoto M, Roppongi T, Nomoto M, Takahashi Y, et al. First case of Myhre syndrome with schizophrenia. Clin Dysmorphol. 2021;30:207–8. (PMID: 10.1097/MCD.000000000000038634456243)
Di Cesare T, Rossi G, Girotto G, Di Nardo W. Benefit of cochlear implantation in a patient with Myhre syndrome. BMJ Case Rep. 2021;14:e243164. (PMID: 10.1136/bcr-2021-243164344335288388303)
Cappuccio G, Caiazza M, Roca A, Melis D, Iuliano A, Matyas G, et al. A pilot clinical trial with losartan in Myhre syndrome. Am J Med Genet A. 2021;185:702–9. (PMID: 10.1002/ajmg.a.6201933369056)
Titomanlio L, Marzano MG, Rossi E, D’Armiento M, De Brasi D, Vega GR, et al. Case of Myhre syndrome with autism and peculiar skin histological findings. Am J Med Genet. 2001;103:163–5. (PMID: 10.1002/ajmg.151711568925)
Kenis C, Verstreken M, Gieraerts K, De Foer B, Van der Aa N, Offeciers EF, et al. Bilateral otospongiosis and a unilateral vestibular schwannoma in a patient with Myhre syndrome. Otol Neurotol. 2014;35:e253–5. (PMID: 10.1097/MAO.000000000000031424841914)
Starr LJ, Grange DK, Delaney JW, Yetman AT, Hammel JM, Sanmann JN, et al. Myhre syndrome: clinical features and restrictive cardiopulmonary complications. Am J Med Genet A. 2015;167a:2893–901. (PMID: 10.1002/ajmg.a.3727326420300)
Starr LJ, Lindsay ME, Perry D, Gheewalla G, VanderLaan PA, Majid A, et al. Review of the pathologic characteristics in Myhre syndrome: gain-of-function pathogenic variants in SMAD4 cause a multisystem fibroproliferative response. Pediatr Dev Pathol. 2022;25:611–23. (PMID: 10.1177/1093526622107956936120950)
Alape D, Singh R, Folch E, Fernandez Bussy S, Agnew A, Majid A. Life-threatening multilevel airway stenosis due to Myhre syndrome. Am J Respir Crit Care Med. 2020;201:731–2. (PMID: 10.1164/rccm.201905-0922IM31539271)
Artemios P, Areti S, Katerina P, Helen F, Eirini T, Charalambos P. Autism spectrum disorder and psychiatric comorbidity in a patient with Myhre syndrome. J Autism Dev Disord. 2019;49:3031–5. (PMID: 10.1007/s10803-019-04015-y30968316)
Rulli I, Ferrero GB, Belligni E, Delmonaco AG, Defilippi C, Silengo M. Myhre’s syndrome in a girl with normal intelligence. Am J Med Genet A. 2005;134a:100–2. (PMID: 10.1002/ajmg.a.3044415723310)
Le Goff C, Mahaut C, Abhyankar A, Le Goff W, Serre V, Afenjar A, et al. Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat Genet. 2011;44:85–8. (PMID: 10.1038/ng.101622158539)
Yuan B, Neira J, Pehlivan D, Santiago-Sim T, Song X, Rosenfeld J, et al. Clinical exome sequencing reveals locus heterogeneity and phenotypic variability of cohesinopathies. Genet Med. 2019;21:663–75. (PMID: 10.1038/s41436-018-0085-630158690)
Srivastava S, Olson HE, Cohen JS, Gubbels CS, Lincoln S, Davis BT, et al. BRAT1 mutations present with a spectrum of clinical severity. Am J Med Genet A. 2016;170:2265–73. (PMID: 10.1002/ajmg.a.37783272825465532882)
D’Haenens E, Vergult S, Menten B, Dheedene A, Kooy RF, Callewaert B. Expanding the phenotype of B3GALNT2-related disorders. Genes. 2022;13:694. (PMID: 10.3390/genes13040694354565009024883)
Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399:1412–28. (PMID: 10.1016/S0140-6736(22)00323-335397864)
Erdem HB, Sahin I, Tatar A. Myhre syndrome with novel findings: bilateral congenital cortical cataract, bilateral papilledema, accessory nipple, and adenoid hypertrophy. Clin Dysmorphol. 2018;27:12–4. (PMID: 10.1097/MCD.000000000000018828562390)
Hawkes L, Kini U. Myhre syndrome with facial paralysis and branch pulmonary stenosis. Clin Dysmorphol. 2015;24:84–5. (PMID: 10.1097/MCD.000000000000006825486016)
Burglen L, Héron D, Moerman A, Dieux-Coeslier A, Bourguignon JP, Bachy A, et al. Myhre syndrome: new reports, review, and differential diagnosis. J Med Genet. 2003;40:546–51. (PMID: 10.1136/jmg.40.7.546128433311735530)
Khandwala YS, Zhang CA, Lu Y, Eisenberg ML. The age of fathers in the USA is rising: an analysis of 168 867 480 births from 1972 to 2015. Hum Reprod. 2017;32:2110–6. (PMID: 10.1093/humrep/dex26728938735)
Lin AE, Brunetti-Pierri N, Lindsay ME, Schimmenti LA, Starr LJ. Myhre syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews(®). Seattle (WA): University of Washington; 1993.
Belgian F. National consensus and clinical guidance for diagnosis and management of Lynch Syndrome. 2020. https://issuu.com/belgianfapa/docs/brochure&#95;fapa&#95;web .
فهرسة مساهمة: Investigator: J Smith; J Simkins; D Clark; S Karatsinides; S Taylor; I White; P Schultz; K Wears; L Holder; K Young
المشرفين على المادة: 0 (Smad4 Protein)
0 (SMAD4 protein, human)
SCR Disease Name: Growth mental deficiency syndrome of Myhre
تواريخ الأحداث: Date Created: 20240712 Date Completed: 20240902 Latest Revision: 20240920
رمز التحديث: 20240921
مُعرف محوري في PubMed: PMC11369149
DOI: 10.1038/s41431-024-01664-1
PMID: 38997468
قاعدة البيانات: MEDLINE
الوصف
تدمد:1476-5438
DOI:10.1038/s41431-024-01664-1